Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 2Phase 2/3 1

Status

Completed 2

Sponsor Class

INDUSTRY 529OTHER 284NIH 80NETWORK 4FED 2OTHER_GOV 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 1Dermatologic 1

Conditions

Breast Neoplasms 4Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Ovarian Neoplasms 2Neoplasm Metastasis 2Motor Activity 2Thoracic Neoplasms 1Stroke 1Prostatic Neoplasms 1Non-Muscle Invasive Bladder Neoplasms 1Neurofibromatosis 2 1Neoplasms by Site 1Neoplasms 1Myasthenia Gravis 1Melanoma 1Lymphoproliferative Disorders 1Lung Diseases 1Liver Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Hematologic Neoplasms 1Glioma 1Glioblastoma 1Esophageal Neoplasms 1Diabetes Mellitus 1Coronary Disease 1Condylomata Acuminata 1Colorectal Neoplasms 1Carcinoma, Bronchogenic 1Breast Neoplasms, Male 1

Interventions

ADI PEG20 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × FED × Neoplasm Metastasis × Clear all
NCT00029900 2015-03-25

ADI-PEG in Patients With Metastatic Melanoma

FDA Office of Orphan Products Development

Phase 1 Completed
15 enrolled
Dermatologic

Melanoma, Neoplasm Metastasis

NCT00108264 2009-01-21

Tumor RNA Transfected Dendritic Cell Vaccines

VA Office of Research and Development

Phase 1 Completed
Genitourinary

Motor Activity, Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡